Greg Parekh
Founder at New Rhein Healthcare Investors
Profile
Greg Parekh, PhD
Founder & Managing Partner
Greg Parekh is the founder and a Managing Partner of New Rhein.
Before launching New Rhein, Greg led the integration planning for Alcon on behalf of Novartis AG, where he previously ran the Mergers & Acquisitions group from 2004 to 2009.
During his time at Novartis, Greg helped execute over 20 transactions with a total deal value of more than $70 billion.
Prior to joining Novartis, Greg headed Deutsche Bank’s European Healthcare Group from 1998 to 2004.
Greg joined Deutsche Bank from Bear Stearns in New York, where he started his career in 1995 as an associate in the Life Sciences group.
Greg has served as a director of the companies in which New Rhein made it initial deal-by-deal investments, Novagali Pharma, SA (a Paris, France based ophthalmology company), Chase Pharmaceuticals, a U.S.
Alzheimer’s drug company, and Biocartis NV, a Belgian oncology diagnostics company, for which Greg also served as Chief Executive Officer from 2011 to 2013.
Greg presently serves on the boards of Fund 18 portfolio companies, Softhale NV and Neuraptive Therapeutics, Inc., Butterfly Medical Ltd.
and is a director of Cancerlinq, a big-data digital healthcare platform and wholly owned subsidiary of the American Society of Clinical Oncology (ASCO).
Greg holds a Ph.D.
in Economics from Northwestern University, an executive leadership program certificate from Harvard Business School and a dual-major B.A.
from University of Rochester (magna cum laude).
Greg's hobbies include gourmet cooking, downhill skiing and music.
Greg Parekh active positions
| Companies | Position | Start |
|---|---|---|
| Everlam SA | Chairman | - |
Softhale NV
 Softhale NV Miscellaneous Commercial ServicesCommercial Services Softhale NV engages in manufacturing medical, clinical and pharmaceutical equipment. The company was founded by Jurgen Rawert and Frank Bartels and is headquartered in Diepenbeek, Belgium. | Director/Board Member | - |
Neuraptive Therapeutics, Inc.
 Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | Director/Board Member | 1989-12-31 |
New Rhein Healthcare Investors
 New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania. | Founder | 2010-08-31 |
CancerLinQ LLC
 CancerLinQ LLC Data Processing ServicesTechnology Services CancerLinQ LLC is a real-world oncology data platform developed by ASCO that collects and aggregates longitudinal electronic health record data from oncology practices throughout the world. The non-profit company is based in Alexandria, VA. The platform aims to improve the quality of patient care and accelerate discovery by securely compiling, harmonizing, analyzing, and de-identifying vast amounts of information on patient characteristics, treatments, and long-term side effects. By using data from nearly 7 million patient records in near real-time, CancerLinQ can improve health outcomes for all patients with cancer and advance evidence-based research. The company was founded in 2014. The CEO is Sean Khozin. | Director/Board Member | - |
Butterfly Medical Ltd. /Isreal/
 Butterfly Medical Ltd. /Isreal/ Medical SpecialtiesHealth Technology Butterfly Medical Ltd. develops implantable device for the treatment of benign prostatic hyperplasia. The company was founded by Adrian Paz and Yehuda Bachar in November 2018 and is headquartered in Yokneam, Israel. | Director/Board Member | 2020-06-30 |
American Injectables, Inc.
 American Injectables, Inc. Pharmaceuticals: MajorHealth Technology American Injectables, Inc. engages in the manufacture of parenteral drugs. Its products include ready-to-use pre-filled syringes and vials. The company is headquartered in Tampa, FL. | Director/Board Member | 2020-07-31 |
Former positions of Greg Parekh
| Companies | Position | End |
|---|---|---|
| BIOCARTIS GROUP NV | Chief Executive Officer | 2013-03-31 |
Chase Pharmaceuticals Corp.
 Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC. | Director/Board Member | - |
| ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░ ░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░ | - |
Training of Greg Parekh
| Rochester Christian University | Undergraduate Degree |
| Northwestern University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| NOVARTIS AG | Health Technology |
| DEUTSCHE BANK AG | Finance |
| BIOCARTIS GROUP NV | Health Technology |
| Private companies | 9 |
|---|---|
New Rhein Healthcare LLC
 New Rhein Healthcare LLC Investment ManagersFinance New Rhein Healthcare LLC operates as private equity investment firm focused on healthcare therapeutics and medical devices. It invests in businesses which utilize proven products in new applications. The company was founded by Greg Parekh in 2010 and is headquartered in Chicago, IL. | Finance |
Chase Pharmaceuticals Corp.
Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC. | Health Technology |
| Everlam SA | |
Softhale NV
Softhale NV Miscellaneous Commercial ServicesCommercial Services Softhale NV engages in manufacturing medical, clinical and pharmaceutical equipment. The company was founded by Jurgen Rawert and Frank Bartels and is headquartered in Diepenbeek, Belgium. | Commercial Services |
Neuraptive Therapeutics, Inc.
Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | Health Technology |
New Rhein Healthcare Investors
New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
CancerLinQ LLC
CancerLinQ LLC Data Processing ServicesTechnology Services CancerLinQ LLC is a real-world oncology data platform developed by ASCO that collects and aggregates longitudinal electronic health record data from oncology practices throughout the world. The non-profit company is based in Alexandria, VA. The platform aims to improve the quality of patient care and accelerate discovery by securely compiling, harmonizing, analyzing, and de-identifying vast amounts of information on patient characteristics, treatments, and long-term side effects. By using data from nearly 7 million patient records in near real-time, CancerLinQ can improve health outcomes for all patients with cancer and advance evidence-based research. The company was founded in 2014. The CEO is Sean Khozin. | Technology Services |
Butterfly Medical Ltd. /Isreal/
Butterfly Medical Ltd. /Isreal/ Medical SpecialtiesHealth Technology Butterfly Medical Ltd. develops implantable device for the treatment of benign prostatic hyperplasia. The company was founded by Adrian Paz and Yehuda Bachar in November 2018 and is headquartered in Yokneam, Israel. | Health Technology |
American Injectables, Inc.
American Injectables, Inc. Pharmaceuticals: MajorHealth Technology American Injectables, Inc. engages in the manufacture of parenteral drugs. Its products include ready-to-use pre-filled syringes and vials. The company is headquartered in Tampa, FL. | Health Technology |
- Stock Market
- Insiders
- Greg Parekh
